Based on the lack of activity that is publicly available, you'd have to assume the answer is yes. Sadly I think the answer will "no, they're needed.."
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025